Oncology Med Signs Multi-Year Contract With Meadville Medical Center's New Comprehensive Cancer Treatment Facility
26 Noviembre 2007 - 8:00AM
Marketwired
PITTSBURGH, PA , a Pittsburgh-based cancer treatment solutions
group, announced today that it has signed a new multi-year
exclusive contract with the Meadville Medical Center in Meadville,
Pennsylvania providing Meadville's state-of-the-art, full-service
cancer treatment center with a full range of medical physics
support to include radiation shielding design and analysis,
equipment acceptance and commissioning and on-going medical physics
consulting services. Oncology Med was selected by Meadville over
several competitors.
According to William Walker, Ph.D., Oncology Med's CEO and
founder, "We are excited to have been made a part of this
innovative project. The center will include the latest and best
available treatment modalities in a unique patient friendly
environment. While many major hospital systems do have their own
internal cancer programs and physics departments and staff,
Oncology Med is seeing a substantial increase in the number of
hospitals contracting those programs and services, either in whole
or in part, to outside agencies such as ours to meet the growing
demands of staff and technology as radiation treatment expands to
be the key treatment of choice for most cancer patients," Walker
contended.
Oncology Med's Vice President of Business Development Jack Sloan
added, "We are on schedule to significantly increase our revenues
through new contracts both in the traditional medical physics arena
and with our new Brachytherapy initiatives. This new contract
demonstrates our continued dominance in our market and is another
of the many new contracts that we hope to announce to our investors
and other interested parties over the next several quarters. We
also anticipate at least two or three additional new major
contracts in the first quarter of the new year as we are
aggressively pursuing new clients and contracted sites."
"We consider our company to be unique in the market in
comparison to other turnkey cancer service providers who are only
capable of offering one or two basic services. Oncology Med can
enter the competitive arena of turnkey cancer solutions with all
services under one roof, provide faster installation of new
programs, equipment, services, and staff, and do so at a lower cost
to the client than our competitors. Oncology Med is a full-service
clinical company to which many management companies have turned in
the past to fulfill their obligations in providing turnkey cancer
solutions."
In addition to physics staffing and support, Oncology Med
continues to expand and provide extensive consultation services for
new and expanded cancer center construction, certification, and
credentialing processes for Joint Commission, as well as, complete
turnkey programs for continuation or implementation of radiation
treatment programs for ambulatory surgery centers, radiation
oncologists, urologists, and hospitals.
About Oncology Med, Inc.
Oncology Med is a public company engaged in the fulfillment of
services related to the treatment of various cancers. It currently
provides analysis and design of radiation treatment plans in order
for radiation oncologists to administer radiation treatments to
cancer patients. Current services facilitate radiation treatment
programs ranging from external beam radiation to more advanced
radiation treatment technologies.
More information about Oncology Med, Inc. can be found at
www.oncologymed.com.
NOTE: This press release may contain "forward-looking
statements." In some cases, you can identify forward-looking
statements by terminology such as "may," "will," "should," "could,"
"expects," "plans," "intends," "anticipates," "believes,"
"estimates," "predicts," "potential," "continue" or the negative of
such terms and other comparable terminology. These forward-looking
statements include, without limitation, statements about our market
opportunity, our strategies, competition, expected activities and
expenditures as we pursue our business plan, and the adequacy of
our available cash resources. Although we believe that the
expectations reflected in any forward-looking statements are
reasonable, we cannot guarantee future results, levels of activity,
performance or achievements. Actual results may differ materially
from the predictions discussed in these forward-looking statements.
Changes in the circumstances upon which we base our predictions
and/or forward-looking statements could materially affect our
actual results.
For information, please contact: Mr. Trevor Bentley Investor
Communications Bentley Communications 1-888-818-8738 Email
Contact
Bellatora (PK) (USOTC:ECGR)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Bellatora (PK) (USOTC:ECGR)
Gráfica de Acción Histórica
De May 2023 a May 2024